Concert Pharmaceuticals, Inc. Deferred Revenue (Non-Current)
Concert Pharmaceuticals, Inc. had Deferred Revenue (Non-Current) of $9.12 million as of 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-05-03
- 2018-03-31: Deferred Revenue, Noncurrent $9.12M.
- 2017-12-31: Deferred Revenue, Noncurrent $8.86M.
- 2017-09-30: Deferred Revenue, Noncurrent $8.92M.
- 2017-06-30: Deferred Revenue, Noncurrent $8.86M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2018-03-31 | $9.12M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $8.86M 10-Q · filed 2018-05-03 |
| 2017-09-30 | $8.92M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $8.86M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $8.87M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $8.88M 10-K · filed 2018-03-01 |
| 2016-09-30 | $8.85M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $8.87M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $8.88M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $8.89M 10-K · filed 2017-03-06 |
| 2015-09-30 | $8.89M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $8.90M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $9.26M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $9.87M 10-K · filed 2016-03-01 |
| 2014-09-30 | $10.63M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $11.15M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $13.95M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $15.31M 10-K · filed 2015-03-02 |